Jean-Paul Henry Selected Research

Jean-Paul Henry Research Topics

Disease

11	Heart Failure 01/2021 - 08/2002
7	Myocardial Infarction 01/2019 - 11/2008
5	Left Ventricular Dysfunction 01/2021 - 09/2005
3	Ischemia 01/2019 - 05/2007
3	Fibrosis (Cirrhosis) 04/2016 - 08/2011
2	Inflammation (Inflammations) 01/2020 - 05/2014
2	Infarction (Infarctions) 01/2020 - 05/2007
2	Hypertrophy 06/2012 - 03/2011
2	Cardiomegaly (Heart Hypertrophy) 08/2011 - 06/2011
2	Cardiomyopathies (Cardiomyopathy) 02/2007 - 09/2005
1	Weight Gain 01/2021
1	Ventricular Remodeling 08/2017
1	Sepsis (Septicemia) 05/2014
1	Insulin Resistance 06/2012
1	Hypoxia (Hypoxemia) 03/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Hypertension (High Blood Pressure) 06/2011
1	Renovascular Hypertension (Goldblatt Syndrome) 06/2011
1	Systemic Scleroderma (Systemic Sclerosis) 12/2008
1	Hyperplasia 05/2007
1	Cardiac Arrhythmias (Arrythmia) 04/2007
1	Heart Diseases (Heart Disease) 10/2006
1	Body Weight (Weight, Body) 09/2005
1	Cocaine-Related Disorders (Cocaine Addiction) 09/2005
1	Cardiotoxicity 08/2004

Drug/Important Bio-Agent (IBA)

3	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2016 - 12/2006
3	Cocaine (Cocaine HCl)IBA 02/2007 - 08/2004
2	Insulin (Novolin)FDA Link 01/2021 - 06/2012
2	finerenoneIBA 01/2021 - 04/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 04/2015
2	Biomarkers (Surrogate Marker)IBA 08/2017 - 01/2011
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2015 - 08/2011
2	Protein Tyrosine PhosphatasesIBA 08/2014 - 12/2006
2	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 05/2014 - 06/2012
2	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2011 - 05/2007
2	Endothelins (Endothelin)IBA 12/2008 - 08/2002
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2006 - 08/2002
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2006 - 08/2002
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2020
1	Vascular Endothelial Growth Factor CIBA 01/2020
1	Galectin 3 (LGALS3)IBA 01/2019
1	gevokizumabIBA 08/2017
1	InterleukinsIBA 08/2017
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 04/2016
1	Capsules (Microcapsules)IBA 04/2015
1	AlginatesIBA 04/2015
1	matrigelIBA 04/2015
1	AlbuminsIBA 04/2015
1	Therapeutic UsesIBA 05/2014
1	LipopolysaccharidesIBA 05/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2012
1	Atrial Natriuretic Factor (ANF)IBA 06/2012
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2012
1	IvabradineIBA 03/2012
1	AutoantigensIBA 01/2012
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 08/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2011
1	Epoxide HydrolasesIBA 06/2011
1	AcidsIBA 06/2011
1	12-(3-adamantan-1-ylureido)dodecanoic acidIBA 06/2011
1	Drinking WaterIBA 06/2011
1	NS 1619IBA 06/2011
1	Fluconazole (Zonal)FDA LinkGeneric 06/2011
1	CalciumIBA 03/2011
1	Troponin T (Troponin T1)IBA 01/2011
1	Estrogen ReceptorsIBA 12/2010
1	Estrogen Receptor alphaIBA 12/2010
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2010
1	Proteins (Proteins, Gene)FDA Link 11/2008
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2008
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 11/2008
1	Crystallins (Crystallin)IBA 11/2008
1	PeroxiredoxinsIBA 11/2008
1	fucoidanIBA 05/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2007
1	Vehicle Emissions (Emissions, Vehicle)IBA 04/2007
1	Air Pollutants (Pollutants, Air)IBA 04/2007
1	Xanthine OxidaseIBA 02/2007
1	NADP (NADPH)IBA 02/2007
1	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2005
1	Endothelin A ReceptorIBA 08/2002

Therapy/Procedure

5	Therapeutics 01/2020 - 08/2002
5	Ligation 04/2016 - 04/2007
1	Ovariectomy (Oophorectomy) 01/2021
1	Punctures 05/2014
1	Injections 08/2011
1	Homologous Transplantation 05/2007